• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

adjuvant

handshake deal shake hand arrows ok yes
Favicon Fierce Pharma

Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals

Several other pharma companies have signed material transfer agreements so that they can experiment with Novavax's Matrix-M before committing to a deal.
Angus Liu Apr 6, 2026 8:37am
Completing steps towards success checkmark on cubes symbolizing progress

Merck, Moderna sustain 49% melanoma risk reduction at 5 years

Jan 20, 2026 8:50am
An arrow incrementally going up stairs before pointing straight up Blue background

Roche links SERD to 30% breast cancer risk reduction in phase 3

Dec 10, 2025 8:15am
unlabeled vaccine

'Active' vaccine adjuvant boosts COVID, flu antibodies in mice

Jul 9, 2024 4:00am
CureVac

CureVac rethinks lead cancer program after posting PD-1 data

Nov 16, 2022 8:30am
Novavax

Novavax BA.1 booster data support COVID-19 vaccine strain switch

Nov 8, 2022 9:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings